50 /100
MEDIUM RISK
Score updated May 30, 2026

HRGN — Harvard Apparatus Regenerative Technology Inc. Dilution Risk Tracker

Track HRGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HRGN — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
85
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
41%
🔄 Reverse Split 45%
• 50-day avg $1.55 approaching $1 threshold
• Only 3 months cash — financial pressure
📉 Score Deterioration 40%
• Score rose 26 points recently (worsening)
💰 Capital Raise 35%
• Low cash runway: 3 months remaining
🔔 Track HRGN — Get forecast alerts →

💹 Market Data

Market Cap$20.92M
Shares Outstanding17.58M
Float8.63M
Cash$419.0K
Debt$173.0K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest60
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2024
8-K 8K EVENT Apr 15, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track HRGN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HRGN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for HRGN
📊 HRGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HRGN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.